Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Follow-up in Type 2 Diabetic Patients 70 Years Old and Over : a Cohort Study.

• Patients suffering from type 2 diabetes and aged 70 and over.
• Having received medicinal or non-medicinal therapy (in the case of diabetics treated with insulin, the lengh of time between diagnosis of diabtees and the introduction of insulin therapy is at least 6 months).
• Suffering from type 2 diabetes at least one year.
• With autonomy defined by a score greater than or equal to 3/6 on the ADL scale and able of being followed-up during hospital or private consultations over the next 5 years.
• Patients who did not refuse to participate in the study after receiving information on the study (Patient Information Leaflet).

The patient are monitored in the hospital or private sector throughout Metropolitan France.

Inclusion Criteria:

• Patient with type 2 diabetes, aged 70 and over,
• Patient having received medicinal or non-medicinal treatment (in the case of diabetics treated with insulin, the length of time between diagnosis of diabetes and the onset of insulin therapy will be at least 2 years),
• Diabetes diagnosed for at least one year,
• Patient with autonomy defined by a score greater than or equal to 3/6 on the ADL scale,
• Patient who can be monitored during hospital or private consultations over the next 10 years,
• Patient who did not refuse to take part in the study after receiving information on the study (Patient Information Leaflet), Patients are monitored in the hospital or private sector throughout France.

Exclusion Criteria:

• Patient with type 1 diabetes,
• Patient with secondary diabetes (mainly corticosteroid-induced),
• Patient with a loss of autonomy defined by a score of less than 3/6 on the ADL scale,
• Patient who cannot be monitored in the months or years to come,
• Patient in an acute situation (transient exclusion criterion),
• Patient expressing their refusal to participate in the study.